Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

USA - NYSE:CLH - US1844961078 - Common Stock

233.95 USD
+1.73 (+0.74%)
Last: 10/10/2025, 9:18:18 PM
233.95 USD
0 (0%)
After Hours: 10/10/2025, 9:18:18 PM
Fundamental Rating

5

Taking everything into account, CLH scores 5 out of 10 in our fundamental rating. CLH was compared to 84 industry peers in the Commercial Services & Supplies industry. While CLH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CLH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CLH was profitable.
CLH had a positive operating cash flow in the past year.
CLH had positive earnings in each of the past 5 years.
In the past 5 years CLH always reported a positive cash flow from operatings.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

With a decent Return On Assets value of 5.17%, CLH is doing good in the industry, outperforming 71.43% of the companies in the same industry.
CLH's Return On Equity of 14.18% is fine compared to the rest of the industry. CLH outperforms 78.57% of its industry peers.
The Return On Invested Capital of CLH (7.62%) is better than 71.43% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLH is in line with the industry average of 10.21%.
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROIC 7.62%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 6.48%, CLH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CLH has grown nicely.
Looking at the Operating Margin, with a value of 10.96%, CLH is in the better half of the industry, outperforming 73.81% of the companies in the same industry.
CLH's Operating Margin has improved in the last couple of years.
The Gross Margin of CLH (30.76%) is comparable to the rest of the industry.
CLH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLH is creating some value.
The number of shares outstanding for CLH remains at a similar level compared to 1 year ago.
The number of shares outstanding for CLH has been reduced compared to 5 years ago.
The debt/assets ratio for CLH is higher compared to a year ago.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.38 indicates that CLH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.38, CLH is in the better half of the industry, outperforming 69.05% of the companies in the same industry.
CLH has a debt to FCF ratio of 7.39. This is a slightly negative value and a sign of low solvency as CLH would need 7.39 years to pay back of all of its debts.
The Debt to FCF ratio of CLH (7.39) is better than 63.10% of its industry peers.
CLH has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CLH (1.02) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Altman-Z 3.38
ROIC/WACC0.96
WACC7.95%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 2.45 indicates that CLH has no problem at all paying its short term obligations.
CLH's Current ratio of 2.45 is fine compared to the rest of the industry. CLH outperforms 77.38% of its industry peers.
CLH has a Quick Ratio of 2.07. This indicates that CLH is financially healthy and has no problem in meeting its short term obligations.
CLH's Quick ratio of 2.07 is amongst the best of the industry. CLH outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.07
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

CLH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.79%.
The Earnings Per Share has been growing by 31.46% on average over the past years. This is a very strong growth
CLH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.49%.
The Revenue has been growing by 11.54% on average over the past years. This is quite good.
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.25% on average over the next years. This is quite good.
CLH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.88% yearly.
EPS Next Y3.26%
EPS Next 2Y10.81%
EPS Next 3Y15.54%
EPS Next 5Y12.25%
Revenue Next Year2.72%
Revenue Next 2Y4.08%
Revenue Next 3Y5.44%
Revenue Next 5Y4.88%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.86, the valuation of CLH can be described as expensive.
CLH's Price/Earnings ratio is in line with the industry average.
CLH is valuated rather expensively when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 25.68 indicates a quite expensive valuation of CLH.
CLH's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.57. CLH is around the same levels.
Industry RankSector Rank
PE 32.86
Fwd PE 25.68
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLH is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CLH is valued a bit cheaper than the industry average as 60.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 33.34
EV/EBITDA 13.31
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLH does not grow enough to justify the current Price/Earnings ratio.
CLH has a very decent profitability rating, which may justify a higher PE ratio.
CLH's earnings are expected to grow with 15.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.08
PEG (5Y)1.04
EPS Next 2Y10.81%
EPS Next 3Y15.54%

0

5. Dividend

5.1 Amount

No dividends for CLH!.
Industry RankSector Rank
Dividend Yield N/A

CLEAN HARBORS INC

NYSE:CLH (10/10/2025, 9:18:18 PM)

After market: 233.95 0 (0%)

233.95

+1.73 (+0.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners92.69%
Inst Owner Change0%
Ins Owners5.55%
Ins Owner Change-3.87%
Market Cap12.55B
Analysts81.25
Price Target262.49 (12.2%)
Short Float %2.64%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.54%
Min EPS beat(2)-2.32%
Max EPS beat(2)1.24%
EPS beat(4)2
Avg EPS beat(4)1.98%
Min EPS beat(4)-3.86%
Max EPS beat(4)12.88%
EPS beat(8)5
Avg EPS beat(8)1.75%
EPS beat(12)9
Avg EPS beat(12)4.09%
EPS beat(16)13
Avg EPS beat(16)10.5%
Revenue beat(2)0
Avg Revenue beat(2)-2.66%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)-1.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)0.03%
Revenue beat(8)3
Avg Revenue beat(8)-1.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.41%
Revenue beat(16)10
Avg Revenue beat(16)1.55%
PT rev (1m)-3.08%
PT rev (3m)1.91%
EPS NQ rev (1m)-0.51%
EPS NQ rev (3m)2.17%
EPS NY rev (1m)0.49%
EPS NY rev (3m)-0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-1.37%
Valuation
Industry RankSector Rank
PE 32.86
Fwd PE 25.68
P/S 2.11
P/FCF 33.34
P/OCF 16.67
P/B 4.62
P/tB 22.52
EV/EBITDA 13.31
EPS(TTM)7.12
EY3.04%
EPS(NY)9.11
Fwd EY3.89%
FCF(TTM)7.02
FCFY3%
OCF(TTM)14.04
OCFY6%
SpS110.8
BVpS50.61
TBVpS10.39
PEG (NY)10.08
PEG (5Y)1.04
Profitability
Industry RankSector Rank
ROA 5.17%
ROE 14.18%
ROCE 10.13%
ROIC 7.62%
ROICexc 8.55%
ROICexgc 13.72%
OM 10.96%
PM (TTM) 6.48%
GM 30.76%
FCFM 6.33%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
ROICexc(3y)9.76%
ROICexc(5y)8.32%
ROICexgc(3y)16.3%
ROICexgc(5y)13.8%
ROCE(3y)11.52%
ROCE(5y)9.73%
ROICexcg growth 3Y10.92%
ROICexcg growth 5Y12.41%
ROICexc growth 3Y14.1%
ROICexc growth 5Y9.64%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 7.39
Debt/EBITDA 2.55
Cap/Depr 86.82%
Cap/Sales 6.34%
Interest Coverage 4.19
Cash Conversion 69.4%
Profit Quality 97.81%
Current Ratio 2.45
Quick Ratio 2.07
Altman-Z 3.38
F-Score7
WACC7.95%
ROIC/WACC0.96
Cap/Depr(3y)108.74%
Cap/Depr(5y)95.27%
Cap/Sales(3y)7.36%
Cap/Sales(5y)6.97%
Profit Quality(3y)77.75%
Profit Quality(5y)110.67%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.79%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-4.07%
EPS Next Y3.26%
EPS Next 2Y10.81%
EPS Next 3Y15.54%
EPS Next 5Y12.25%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%-0.18%
Revenue Next Year2.72%
Revenue Next 2Y4.08%
Revenue Next 3Y5.44%
Revenue Next 5Y4.88%
EBIT growth 1Y1.33%
EBIT growth 3Y24.78%
EBIT growth 5Y23.92%
EBIT Next Year74.56%
EBIT Next 3Y28.7%
EBIT Next 5Y19.79%
FCF growth 1Y15.34%
FCF growth 3Y3.81%
FCF growth 5Y11.72%
OCF growth 1Y3.15%
OCF growth 3Y12.52%
OCF growth 5Y13.49%